Cross-Seal IDE Trial: Prospective, Multicenter, Single-Arm Study of the Cross-Seal Suture-Mediated Vascular Closure Device System
Circulation: Cardiovascular Interventions · 2024
DOI: 10.1161/circinterventions.123.013842 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation: Cardiovascular Interventions, 2024. Verfasst von Prakash Krishnan und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (P.K., S.F., S. …. Hauptthemen laut MEDLINE: Vascular Closure Devices, Hemostatic Techniques, Suture Techniques, Endovascular Procedures. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: An increasing number of interventional procedures require large-sheath technology (>12F) with a favorable outcome with endovascular rather than open surgical access. However, vascular complications are a limitation for the management of these patients. This trial aimed to determine the effectiveness and safety of the Cross-Seal suture-mediated vascular closure device in obtaining hemostasis at the target limb access site following interventional procedures using 8F to 18F procedural sheaths. METHODS: The Cross-Seal IDE trial (Investigational Device Exemption) was a prospective, single-arm, multicenter study in subjects undergoing percutaneous endovascular procedures utilizing 8F to 18F ID procedural sheaths. The primary efficacy end point was time to hemostasis at the target limb access site. The primary safety end point was freedom from major complications of the target limb access site within 30 days post procedure. RESULTS: A total of 147 subjects were enrolled between August 9, 2019, and March 12, 2020. Transcatheter aortic valve replacement was performed in 53.7% (79/147) and percutaneous endovascular abdominal/thoracic aortic aneurysm repair in 46.3% (68/147) of subjects. The mean sheath ID was 15.5±1.8 mm. The primary effectiveness end point of time to hemostasis was 0.4±1.4 minutes. An adjunctive intervention was required in 9.2% (13/142) of subjects, of which 2.1% (3/142) were surgical and 5.6% (8/142) endovascular. Technical success was achieved in 92.3% (131/142) of subjects. Freedom from major complications of the target limb access site was 94.3% (83/88). CONCLUSIONS: In selected patients undergoing percutaneous endovascular procedures utilizing 8F to 18F ID procedural sheath, Cross-Seal suture-mediated vascular closure device achieved favorable effectiveness and safety in the closure of the large-bore arteriotomy. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03756558.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (P.K., S.F., S. Khera).
- Department of Cardiology, Austin Heart, TX (F.Z.).
- Department of Vascular Surgery, Texas Heart Institute, Houston (Z.K.).
- Department of Cardiology, Wellmont Holston Valley Medical Center, Kingsport, TN (C.M.).
- Department of Cardiology, Cleveland Clinic, OH (S. Kapadia).
- Department of Vascular Surgery, River City Clinical Research, Jacksonville, FL (E.M.).
ORCID-Profile: Prakash Krishnan, Samir Kapadia, Sahil Khera, Virendra I Patel, Marc L Schermerhorn, Jean M Panneton
Zitieren
APA
Krishnan, P., Farhan, S., Zidar, F., Krajcer, Z., Metzger, C., Kapadia, S., Moore, E., Nazif, T., Garland, T., Zhang, M., Khera, S., Sharafuddin, M., Patel, V. I., Bacharach, J. M., Coady, P., Schermerhorn, M. L., Shames, M. L., Rahimi, S., Panneton, J. M., …, & Foteh, M. (2024). Cross-Seal IDE Trial: Prospective, Multicenter, Single-Arm Study of the Cross-Seal Suture-Mediated Vascular Closure Device System. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.123.013842
Vancouver
Krishnan P, Farhan S, Zidar F, Krajcer Z, Metzger C, Kapadia S, et al. Cross-Seal IDE Trial: Prospective, Multicenter, Single-Arm Study of the Cross-Seal Suture-Mediated Vascular Closure Device System. Circulation: Cardiovascular Interventions. 2024. doi:10.1161/circinterventions.123.013842
BibTeX
@article{Krishnan2024,
author = {Krishnan, Prakash and Farhan, Serdar and Zidar, Frank and Krajcer, Zvonimir and Metzger, Christopher and Kapadia, Samir and Moore, Erin and Nazif, Tamim and Garland, Ty and Zhang, Ming and Khera, Sahil and Sharafuddin, Mel and Patel, Virendra I and Bacharach, John Michael and Coady, Paul and Schermerhorn, Marc L and Shames, Murray L and Rahimi, Saum and Panneton, Jean M and Elkins, Craig and Foteh, Mazin},
title = {Cross-Seal IDE Trial: Prospective, Multicenter, Single-Arm Study of the Cross-Seal Suture-Mediated Vascular Closure Device System},
journal = {Circulation: Cardiovascular Interventions},
year = {2024},
doi = {10.1161/circinterventions.123.013842}
}
EUVIMED